Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135453) titled 'Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: University of Alabama at Birmingham
Condition:
Vaccine
Pneumococcal Disease
Intervention:
Biological: Pneumococcal Vaccine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 2025
Target Sample Size: 105
Countries of Recruitment:
United States
To know more, visit https://clinicaltrial...